$4.71
-0.17[-3.48%]
At close: Apr 26
$4.71
0[0.00%]
After Hours: 8:17AM EDT
Affimed
(NASDAQ:AFMD)Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions
Affimed NV has a consensus price target of $7.89, established from looking at the 27 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, Cantor Fitzgerald, and Stifel on April 1, 2024. With an average price target of $10 between Wells Fargo, Cantor Fitzgerald, and Stifel, there's an implied 112.31% upside for Affimed NV from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Cantor Fitzgerald
Stifel
HC Wainwright & Co.
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Affimed
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2024 | AFMD | Buy Now | Affimed | $4.71 | 430.79% | Wells Fargo | Yanan Zhu | $30 → $25 | Maintains | Overweight | Get Alert |
| 04/01/2024 | AFMD | Buy Now | Affimed | $4.71 | — | Cantor Fitzgerald | Li Watsek | — | Reiterates | → Overweight | Get Alert |
| 04/01/2024 | AFMD | Buy Now | Affimed | $4.71 | 6.16% | Stifel | Bradley Canino | $1 → $5 | Maintains | Hold | Get Alert |
| 04/01/2024 | AFMD | Buy Now | Affimed | $4.71 | 112.31% | HC Wainwright & Co. | Swayampakula Ramakanth | $5 → $10 | Maintains | Buy | Get Alert |
| 11/15/2023 | AFMD | Buy Now | Affimed | $4.71 | 6.16% | HC Wainwright & Co. | Swayampakula Ramakanth | → $50 | Reiterates | Buy → Buy | Get Alert |
| 09/25/2023 | AFMD | Buy Now | Affimed | $4.71 | 48.62% | Cantor Fitzgerald | Li Watsek | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/12/2023 | AFMD | Buy Now | Affimed | $4.71 | 48.62% | Cantor Fitzgerald | Li Watsek | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | AFMD | Buy Now | Affimed | $4.71 | 48.62% | Cantor Fitzgerald | Li Watsek | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | AFMD | Buy Now | Affimed | $4.71 | 27.39% | Truist Securities | Srikripa Devarakonda | $80 → $60 | Maintains | Buy | Get Alert |
| 08/11/2023 | AFMD | Buy Now | Affimed | $4.71 | 6.16% | HC Wainwright & Co. | Swayampakula Ramakanth | → $50 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | AFMD | Buy Now | Affimed | $4.71 | 27.39% | Berenberg | Andy Chen | → $60 | Assumes | → Buy | Get Alert |
| 06/05/2023 | AFMD | Buy Now | Affimed | $4.71 | 6.16% | HC Wainwright & Co. | Swayampakula Ramakanth | $60 → $50 | Maintains | Buy | Get Alert |
| 05/24/2023 | AFMD | Buy Now | Affimed | $4.71 | 27.39% | HC Wainwright & Co. | Swayampakula Ramakanth | → $60 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2023 | AFMD | Buy Now | Affimed | $4.71 | 48.62% | Wells Fargo | Yanan Zhu | → $70 | Assumes | → Overweight | Get Alert |
| 03/24/2023 | AFMD | Buy Now | Affimed | $4.71 | -78.77% | Stifel | Bradley Canino | $20 → $10 | Maintains | Hold | Get Alert |
| 03/24/2023 | AFMD | Buy Now | Affimed | $4.71 | 27.39% | HC Wainwright & Co. | Swayampakula Ramakanth | → $60 | Reiterates | → Buy | Get Alert |
| 12/12/2022 | AFMD | Buy Now | Affimed | $4.71 | 48.62% | Wells Fargo | James Shin | $80 → $70 | Maintains | Overweight | Get Alert |
| 12/12/2022 | AFMD | Buy Now | Affimed | $4.71 | 27.39% | Piper Sandler | Do Kim | $70 → $60 | Maintains | Overweight | Get Alert |
| 12/12/2022 | AFMD | Buy Now | Affimed | $4.71 | 27.39% | SVB Leerink | Daina Graybosch | $100 → $60 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Affimed (AFMD)?
The latest price target for Affimed (NASDAQ: AFMD) was reported by Wells Fargo on April 1, 2024. The analyst firm set a price target for $25.00 expecting AFMD to rise to within 12 months (a possible 430.79% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Affimed (AFMD)?
The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Wells Fargo, and Affimed maintained their overweight rating.
When was the last upgrade for Affimed (AFMD)?
There is no last upgrade for Affimed.
When was the last downgrade for Affimed (AFMD)?
The last downgrade for Affimed NV happened on October 10, 2022 when Stifel changed their price target from $9 to $2 for Affimed NV.
When is the next analyst rating going to be posted or updated for Affimed (AFMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
Is the Analyst Rating Affimed (AFMD) correct?
While ratings are subjective and will change, the latest Affimed (AFMD) rating was a maintained with a price target of $30.00 to $25.00. The current price Affimed (AFMD) is trading at is $4.71, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.